home All News open_in_new Full Article

Lilly adquiere Verve Therapeutics por hasta 1.300 millones de dólares

La compañía está especializada en medicamentos genéticos para enfermedades cardiovasculares. Más información: Lilly se corona como la farmacéutica con mayores ingresos en el primer trimestre de 2025


today 44 h. ago attach_file Economics

attach_file Politics
attach_file Politics
attach_file Politics
attach_file Events
attach_file Politics
attach_file Events
attach_file Politics
attach_file Politics
attach_file Events
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Events
attach_file Politics
attach_file Politics
attach_file Events
attach_file Science
attach_file Sport
attach_file Events


ID: 3677929766
Add Watch Country

arrow_drop_down